“Tendonitis Therapies such as TENDAXION, TENDOFIT, ZEPTIDE, TENACTIVE/TENDOACTIVE, TENDOMAC, RITISAL, and others”
The Tendonitis Market is projected to witness substantial growth over the next few years, driven by advancements in treatment modalities and increasing awareness of the condition. The pipeline for o Tendonitis therapeutics includes promising candidates that aim to not only treat acute attacks but also prevent recurrence
DelveInsight’s “Tendonitis Drugs Market Insights, Epidemiology, and Market Forecast-2034” report delivers an in-depth understanding of the Tendonitis, historical and forecasted epidemiology as well as the Tendonitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Unlock detailed insights into the Tendonitis Market by downloading the comprehensive report from DelveInsight @ Tendonitis Therapeutics Market
Key Takeaways from the Tendonitis Market Report
The Growth of the Tendonitis Market is expected to be primarily driven by an expanding patient population, and advancement in diagnostic methods.
The leading Tendonitis Companies such as MiMedex Group Inc, MEDRx USA Inc, Cerimon Pharmaceuticals, InGeneron Inc, ZetrOZ Inc, ZARS Pharma Inc, Smith & Nephew Inc., and others.
Promising Tendonitis Therapies such as TENDAXION, TENDOFIT, ZEPTIDE, TENACTIVE/TENDOACTIVE, TENDOMAC, RITISAL, and others
As per the DelveInsight estimates, the total Tendinopathy Gender-specific cases in the United States was ~8,499,400 and 3,642,600 cases for males and females, respectively in 2022, which are expected to grow during the study period, i.e., 2019–2032.
In August 2024:- Wrightington, Wigan and Leigh NHS Foundation Trust- A Prospective, Double Blind, Single Centre, RCT, Comparing the Effectiveness of Physiotherapy in Addition to One of 3 Types of Image Guided Injection of the Common Extensor Tendon, on Pain and Function in Patients With Tennis Elbow.
Gain a competitive edge in the Tendonitis Market by exploring our in-depth analysis. Visit our website to access the full report and make informed strategic decisions @ Tendonitis Treatment Drugs
Tendonitis Epidemiology Segmentation in the 7MM
• Total Tendonitis Incident Cases
• Tendonitis Type-specific Incident Cases
• Total Tendonitis Treated Cases
• Tendonitis Region-specific Incident Cases
• Tendonitis Gender-specific Incident Cases
Tendinopathy Treatment Market Landscape
The treatment landscape for tendinopathy is rapidly evolving, with numerous companies actively developing new therapies. Around 40-50% of patients currently undergo physiotherapy as part of their treatment. Recently, there’s been a surge in nutraceutical products that appear to support the healing of tendon injuries and may also serve as preventive measures. Although preclinical results are promising, the available literature on this topic remains limited. Managing tendinopathy with oral supplements is still a relatively new approach.
Tendinopathy Market Insights
Tendinopathy refers to a complex and multifaceted condition of the tendon, marked by pain, diminished function, and decreased exercise tolerance. The most frequently affected tendons due to overuse include the rotator cuff, medial and lateral elbow epicondyles, patellar, gluteal, and Achilles tendons. Key histological and molecular characteristics of tendinopathy include collagen fiber disorganization, increased microvasculature and sensory nerve innervation, disrupted extracellular matrix homeostasis, elevated immune cell activity and inflammatory mediators, and heightened cellular apoptosis.
Discover key developments and opportunities in the Tendonitis Market. Click here to learn more from DelveInsight’s latest report @ Tendonitis Market Size
Tendonitis Emerging Drugs
SI-613: Seikagaku Corporation
SI-613 is a formulation in which hyaluronic acid and a non-steroidal anti-inflammatory drug (NSAID) are chemically bound using Seikagaku’s own proprietary technology. SI-613 was designed to provide pain relief and anti-inflammatory effect by sustained release of NSAID, and the joint function improving effect by hyaluronic acid. It is expected to provide prompt and sustained relief of the severe pain and inflammation associated with osteoarthritis and enthesopathy. The drug is currently in phase II of clinical trials for the treatment of Tendonitis.
MP1032: MetrioPharm
MP1032’s mode of action – to accelerate the healing process – allows for the use of MP1032 as a therapeutic for Tendonitis before a tendinosis develops. In addition, MP1032 could accelerate the repair of already damaged tendons and thus also shorten the duration of tendinosis treatments. The drug is currently in phase I of clinical trials for the treatment of Tendonitis.
Tendinopathy Drugs and Companies
OCS-05 IV administration: Oculis
BAT4406F Injection: Bio-Thera Solutions
Ravulizumab: Alexion Pharmaceuticals
B001: Shanghai Drug Research Development Co. Ltd.
Inebilizumab: Hansoh BioMedical R&D Company
Tendinopathy Market Dynamics
The dynamics of the Tendinopathy market are expected to evolve in the coming years. Preclinical models have supported this emerging therapeutic approach, but there is a notable lack of clinical studies involving stem cells for enhancing tendon repair or treating Tendinopathy, especially when compared to scaffolds and growth factors.
Download DelveInsight’s Tendonitis Market report today and stay ahead in this rapidly evolving field. @ Tendonitis Clinical Trials
Scope of the Tendonitis Market Report
Coverage- 7MM
Tendonitis Companies- MiMedex Group Inc, MEDRx USA Inc, Cerimon Pharmaceuticals, InGeneron Inc, ZetrOZ Inc, ZARS Pharma Inc, Smith & Nephew Inc., and others.
Tendonitis Therapies- TENDAXION, TENDOFIT, ZEPTIDE, TENACTIVE/TENDOACTIVE, TENDOMAC, RITISAL, and others
Tendonitis Competitive Intelligence Analysis: SWOT analysis and Market entry strategies
Tendonitis Unmet Needs, KOL’s views, Analyst’s views, Tendonitis Market Access and Reimbursement
Download the report to understand which factors are driving Tendonitis market trends @ Tendonitis Market Trends
Table of Content
1. Key Insights
2. Executive Summary of Tendonitis
3. Competitive Intelligence Analysis for Tendonitis
4. Tendonitis: Market Overview at a Glance
5. Tendonitis: Disease Background and Overview
6. Patient Journey
7. Tendonitis Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Unmet Needs
10. Key Endpoints of Tendonitis Treatment
11. Marketed Products
12. Emerging Therapies
13. Tendonitis: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of Tendonitis
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: 9650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
